About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Bariatric and Obstructive Lung Disease Study II

NCT01127399·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Johns Hopkins University

With

National Heart, Lung, and Blood Institute (NHLBI)

Age

18–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Age 18 years or older
BMI over 35 kg/m2 (Bariatric) or BMI between 25 and 28 kg/m2 (Control)
Physician diagnosis of asthma and on active asthma medication (if asthmatic)

You may not be if

Weight greater than 450 lbs
Unstable cardiovascular disease
Uncontrolled hypertension
Renal failure on dialysis
Cirrhosis
Pregnant or lactating
Bleeding disorders or Coumadin use
Recent hospitalization for asthma in the past 3 months
Active smoking or more than 10 pack year smoking history

The record

StatusTerminated

PhaseNo phase

Taking part40

StartedSep 2009

UpdatedFeb 5, 2018

Conditions

Where1

The Johns Hopkins University, The Johns Hopkins Bayview Medical Campus
Baltimore, Maryland, United States

Clareo Health | Bariatric and Obstructive Lung Disease Study II